Access cutting-edge endometrial cancer treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access endometrial cancer specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related endometrial cancer treatment provided free
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have achieved complete response or partial response on chemotherapy. The study will be conducted in 2 parts. Part 1 will evaluate safety and efficacy of two different doses of navtemadlin alongside an observational control arm to determine the Phase 3 navtemadlin dose. Part 2 will evaluate the efficacy and safety of navtemadlin Phase 3 dose compared to placebo.
Sponsor: Kartos Therapeutics, Inc.
Check if you qualify for this endometrial cancer clinical trial in Atlanta, GA
If you're searching for endometrial cancer treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced endometrial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.